Viewing Study NCT00003305


Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2026-05-21 @ 12:05 AM
Study NCT ID: NCT00003305
Status: COMPLETED
Last Update Posted: 2014-01-06
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Aminopterin in Treating Patients With Refractory Leukemia
Sponsor: Genzyme, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module